Kathrine Redalen

Professor

Norges teknisk-naturvitenskapelige universitet

Norway

Research Interests

Explore related searches

Professors in Norway Professors in Medical Imaging Medical Imaging professors in Norway

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Kathrine Redalen is a Professor at Norges Teknisk-Naturvitenskapelige Universitet in Norway. Her research focuses on the application of advanced imaging techniques and theranostic agents in the treatment of rectal cancer, addressing topics such as metastatic progression, energy metabolism alterations, and sex differences in tumor response. Recent publications include work on serum metabolite levels and quantitative MRI-based analyses related to colorectal cancer outcomes.

Articles (11)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Laure Marignol

Professor in Radiation Biology

Trinity College Dublin

IRELAND

View details

Frode Rise

Professor

University of Oslo

NORWAY

View details

Oliver Gurney-Champion

Assistant Professor

Amsterdam University Medical Centers

NETHERLANDS

View details

Lorraine Brennan

UCD

IRELAND

View details

Fariba Tohidinezhad

University of Maastricht

NETHERLANDS

View details

Anne H. Ree

Oslo University Hospital

NORWAY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kathrine Redalen

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Serum metabolite levels identify incipient metastatic progression of rectal cancer

Quantitative MRI-based radiomics analysis identifies blood flow feature associated to overall survival for rectal cancer patients.

In vitro and in vivo characterization of [64Cu][Cu(elesclomol)] as a novel theranostic agent for hypoxic solid tumors

Next-generation sequencing reveals mitogenome diversity in plasma extracellular vesicles from colorectal cancer patients

Energy Metabolism Is Altered in Radioresistant Rectal Cancer

Sex Differences and Tumor Blood Flow from Dynamic Susceptibility Contrast MRI Are Associated with Treatment Response after Chemoradiation and Long-term Survival in Rectal Cancer

Hypoxia imaging and theranostic potential of [64Cu][Cu(ATSM)] and ionic Cu(II) salts: a review of current evidence and discussion of the retention mechanisms.

Quantitative imaging for radiotherapy purposes.

Corrigendum to “Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer” [Transl Oncol 12 (8) (2019) 1038–1044](S1936523319300919)(10.1016/j.tranon.2019.04.014)

Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer

Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?

Collaborators (6)

Laure Marignol

Frode Rise

Oliver Gurney-Champion

Lorraine Brennan

Fariba Tohidinezhad

Anne H. Ree

Make your next move.